Modulation of inflammation in brain: A matter of fat

Journal of Neurochemistry

Volumn 101, Issue 3, 2007, Pages 577-599

  Farooqui, Akhlaq A ^a   Horrocks, Lloyd A ^a   Farooqui, Tahira ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Arachidonic acid; Cytokines; Docosahexaenoic acid; Docosanoids; Eicosanoids; Neurodegenerative diseases

Indexed keywords

ANANDAMIDE; ARACHIDONIC ACID; CELL ADHESION MOLECULE; CHEMOKINE; COLONY STIMULATING FACTOR 1; CYTOKINE; DOCOSAHEXAENOIC ACID; GLYCEROPHOSPHOLIPID; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 3; INTERLEUKIN 6; LEUKOTRIENE; LINOLEIC ACID; LIPOXIN; LYSOPHOSPHOLIPID; MEMBRANE PHOSPHOLIPID; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHOSPHOLIPASE A2; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; THROMBOCYTE ACTIVATING FACTOR; THROMBOXANE; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARACHIDONIC ACID METABOLISM; BRAIN ISCHEMIA; BRAIN TISSUE; CATALYSIS; CELL MIGRATION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM DISEASE; CHEMICAL REACTION; CONVALESCENCE; CYTOKINE PRODUCTION; DEGENERATIVE DISEASE; DIETARY INTAKE; ENCEPHALITIS; ENZYME ACTIVATION; EPILEPSY; EXCITOTOXICITY; FATTY ACID METABOLISM; GENE EXPRESSION; GLIA CELL; HEART ARRHYTHMIA; HEART INFARCTION; HOST RESISTANCE; HUMAN; HUNTINGTON CHOREA; IMMUNOGLOBULIN A NEPHROPATHY; LEUKOCYTE FUNCTION; MEDIATOR RELEASE; MICROGLIA; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NERVE REGENERATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROSTAGLANDIN SYNTHESIS INHIBITION; REVIEW; SPINAL CORD INJURY;

ANIMALS; BRAIN; HUMANS; INFLAMMATION; LIPID METABOLISM; LIPIDS; MODELS, BIOLOGICAL; NEUROGLIA;

EID: 34247330919     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.04371.x     Document Type: Review

References (261)

1. de Wilde, M. C., Leenders I., Broersen L. M., Kuipers A. A. M., van der Beek E. M. Kiliaan A. J. (2003) The omega-3 fatty acid docosahexaenoic acid (DHA) inhibits the formation of beta amyloid in CHO7PA2 cells. Abstract Viewer/Itinerary Planner, Program No. 730.11. 2003.
2. Adibhatla R. M., Hatcher J. F., Larsen E. C., Chen X. Z., Sun D. D. Tsao F. H. C. (2006) CDP-choline significantly restores phosphatidylcholine levels by differentially affecting phospholipase A2 and CTP: Phosphocholine cytidylyltransferase after stroke. J. Biol. Chem. 281, 6718 6725.
3. Allan S. M. Rothwell N. J. (2003) Inflammation in central nervous system injury. Philos. Trans. R. Soc. Lond B Biol. Sci. 358, 1669 1677.
4. Anrather J., Racchumi G. Iadecola C. (2006) NF-κB regulates phagocytic NADPH oxidase by inducing the expression of gp91phox. J. Biol. Chem. 281, 5657 5667.
5. Anthonsen M. W., Andersen S., Solhaug A. Johansen B. (2001) Atypical / PKC conveys 5-lipoxygenase-leukotriene B-4-mediated cross-talk between phospholipase A2 s regulating NF-κB activation in response to tumor necrosis factor-α and interleukin-1β. J. Biol. Chem. 276, 35 344 35 351.
6. Ariel A., Li P. L., Wang W., Tang W. X., Fredman G., Hong S., Gotlinger K. H. Serhan C. N. (2005) The docosatriene Protectin D1 is produced by TH2 skewing and promotes human T cell apoptosis via lipid raft clustering. J. Biol. Chem. 280, 43 079 43 086.
7. Arita M., Bianchini F., Aliberti J., Sher A., Chiang N., Hong S., Yang R., Petasis N. A. Serhan C. N. (2005a) Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J. Exp. Med. 201, 713 722.
8. Arita M., Yoshida M., Hong S., Tjonahen E., Glickman J. N., Petasis N. A., Blumberg R. S. Serhan C. N. (2005b) Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc. Natl Acad. Sci. USA 102, 7671 7676.
9. Baker D., Pryce G., Croxford J. L. et al. (2001) Endocannabinoids control spasticity in a multiple sclerosis model. FASEB J. 15, 300 302.
10. Balsinde J., Balboa M. A. Dennis E. A. (1997) Inflammatory activation of arachidonic acid signaling in murine P388D1 macrophages via sphingomyelin synthesis. J. Biol. Chem. 272, 20 373 20 377.
11. Barceló-Coblijn G., Kitajka K., Puskás L. G., Högyes E., Zvara A., Hackler L., Jr. Farkas T. (2003) Gene expression and molecular composition of phospholipids in rat brain in relation to dietary n-6 to n-3 fatty acid ratio. Biochim. Biophys. Acta 1632, 72 79.
12. Basu S. (2004) Isoprostanes: Novel bioactive products of lipid peroxidation. Free Radical Res. 38, 105 122.
13. Bazan N. G. (2005a) Lipid signaling in neural plasticity, brain repair, and neuroprotection. Mol. Neurobiol. 32, 89 103.
14. Bazan N. G. (2005b) Neuroprotectin D1 (NPD1): A DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress. Brain Path. 15, 159 166.
15. Bazan N. G. (2005c) Synaptic signaling by lipids in the life and death of neurons. Mol. Neurobiol. 31, 219 230.
16. Bazan N. G. Flower R. J. (2002) Medicine: lipid signals in pain control. Nature 420, 135 138.
17. Bazan N. G., Fletcher B. S., Herschman H. R. Mukherjee P. K. (1994) Platelet-activating factor and retinoic acid synergistically activate the inducible prostaglandin synthase gene. Proc. Natl Acad. Sci. USA 91, 5252 5256.
18. Bazan N. G., Packard M. G., Teather L. Allan G. (1997) Bioactive lipids in excitatory neurotransmission and neuronal plasticity. Neurochem. Int. 30, 225 231.
19. Bechoua S., Dubois M., Vericel E., Chapuy P., Lagarde M. Prigent A. F. (2003) Influence of very low dietary intake of marine oil on some functional aspects of immune cells in healthy elderly people. Br. J. Nutr. 89, 523 531.
20. Beck S., Lambeau G., Scholz-Pedretti K., Gelb M. H., Janssen M. J. W., Edwards S. H., Wilton D. C., Pfeilschifter J. Kaszkin M. (2003) Potentiation of tumor necrosis factor α-induced secreted phospholipase A2 (sPLA2)-IIA expression in mesangial cells by an autocrine loop involving sPLA2 and peroxisome proliferator-activated receptor α activation. J. Biol. Chem. 278, 29 799 29 812.
21. Berdyshev E. V. (2000) Cannabinoid receptors and the regulation of immune response. Chem. Phys. Lipids 108, 169 190.
22. Bernoud-Hubac N., Davies S. S., Boutaud O., Montine T. J., Roberts L. J. II. (2001) Formation of highly reactive gamma-ketoaldehydes (Neuroketals) as products of the neuroprostane pathway. J. Biol. Chem. 276, 30 964 30 970.
23. Birgbauer E., Rao T. S. Webb M. (2004) Lysolecithin induces demyelination in vitro in a cerebellar slice culture system. J. Neurosci. Res. 78, 157 166.
24. Bochkov V. N. Leitinger N. (2003) Anti-inflammatory properties of lipid oxidation products. J. Mol. Med. 81, 613 626.
25. Brites P., Waterham H. R. Wanders R. J. A. (2004) Functions and biosynthesis of plasmalogens in health and disease. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1636, 219 231.
26. Calder F. C. (2005) Polyunsaturated fatty acids and inflammation. Biochem. Soc. Trans. 33, 423 427.
27. Calder P. C. Grimble R. F. (2002) Polyunsaturated fatty acids, inflammation and immunity. Eur. J. Clin. Nutr. 56, S14 S19.
28. Calon F., Lim G. P., Yang F. S. et al. (2004) Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron 43, 633 645.
29. Carrier E. J., Kearn C. S., Barkmeier A. J., Breese N. M., Yang W. Q., Nithipatikom K., Pfister S. L., Campbell W. B. Hillard C. J. (2004) Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism. Mol. Pharmacol. 65, 999 1007.
30. Chalon S., Delion-Vancassel S., Belzung C., Guilloteau D., Leguisquet A. M., Besnard J. C. Durand G. (1998) Dietary fish oil affects monoaminergic neurotransmission and behavior in rats. J. Nutr. 128, 2512 2519.
31. Chen P., Hu S., Yao J., Moore S. A., Spector A. A. Fang X. (2005) Induction of cyclooxygenase-2 by anandamide in cerebral microvascular endothelium. Microvasc. Res. 69, 28 35.
32. Chen C. C., Chaung H. C., Chung M. Y. Huang L. T. (2006) Menhaden fish oil improves spatial memory in rat pups following recurrent pentylenetetrazole- induced seizures. Epilepsy & Behavior 8, 516 521.
33. Chiang N., Arita M. Serhan C. N. (2005) Anti-inflammatory circuitry: Lipoxin, aspirin-triggered lipoxins and their receptor ALX. Prostaglandins Leukot. Essent. Fatty Acids 73, 163 177.
34. Clemens J. A., Stephenson D. T., Smalstig E. B., Roberts E. F., Johnstone E. M., Sharp J. D., Little S. P. Kramer R. M. (1996) Reactive glia express cytosolic phospholipase A2 after transient global forebrain ischemia in the rat. Stroke 27, 527 535.
35. Cole G. M., Lim G. P., Yang F., Teter B., Begum A., Ma Q., Harris-White M. E. Frautschy S. A. (2005) Prevention of Alzheimer's disease: Omega-3 fatty acid and phenolic anti-oxidant interventions. Neurobiol. Aging 26 (Suppl. 1 133 136.
36. Consilvio C., Vincent A. M. Feldman E. L. (2004) Neuroinflammation, COX-2, and ALS - a dual role? Exp. Neurol. 187, 1 10.
37. Correale J. Villa A. (2004) The neuroprotective role of inflammation in nervous system injuries. J. Neurol. 251, 1304 1316.
38. Cracowski J. L. (2004) Isoprostanes: an emerging role in vascular physiology and disease? Chem. Phys. Lipids 128, 75 83.
39. Craft J. M., Watterson D. M. Van Eldik L. J. (2005) Neuroinflammation: a potential therapeutic target. Expert Opin. Ther. Targets 9, 887 900.
40. Das V. N. Vaddadi K. S. (2004) Essential fatty acids in Huntington's disease. Nutrition 20, 942 947.
41. De Caterina R. Massaro M. (2005) Omega-3 fatty acids and the regulation of expression of endothelial pro-atherogenic and pro-inflammatory genes. J. Membr. Biol. 206, 103 116.
42. DeCoster M. A., Lambeau G., Lazdunski M. Bazan N. G. (2002) Secreted phospholipase A2 potentiates glutamate-induced calcium increase and cell death in primary neuronal cultures. J. Neurosci. Res. 67, 634 645.
43. Diamond P., McGinty A., Sugrue D., Brady H. R. Godson C. (1999) Regulation of leukocyte trafficking by lipoxins. Clin. Chem. Lab Med. 37, 293 297.
44. Donadio J. V. Grande J. P. (2004) The role of fish oil/omega-3 fatty acids in the treatment of IgA nephropathy. Semin. Nephrol. 24, 225 243.
45. Drew P. D., Storer P. D., Xu J. H. Chavis J. A. (2005) Hormone regulation of microglial cell activation: relevance to multiple sclerosis. Brain Res. Rev. 48, 322 327.
46. Ducobu J. (2005) [Innovative therapies in metabolic diseases: ezetimibe (Ezetrol), nicotinic acid (Niaspan), acids omega-3 (Omacor), rimonabant (Acomplia)]. Rev. Med. Brux. 26, S393 S405.
47. Edgar A. D., Strosznajder J. Horrocks L. A. (1982) Activation of ethanolamine phospholipase A2 in brain during ischemia. J. Neurochem. 39, 1111 1116.
48. Engelmann B. (2004) Plasmalogens: targets for oxidants and major lipophilic antioxidants. Biochem. Soc. Trans. 32, 147 150.
49. Fam S. S. Morrow J. D. (2003) The isoprostanes: Unique products of arachidonic acid oxidation - A review. Curr. Medicinal Chem. 10, 1723 1740.
50. Farkas T., Kitajka K., Fodor E., Csengeri I., Lahdes E., Yeo Y. K., Krasznai Z. Halver J. E. (2000) Docosahexaenoic acid-containing phospholipid molecular species in brains of vertebrates. Proc. Natl Acad. Sci. USA 97, 6362 6366.
51. Farooqui A. A. Horrocks L. A. (1991) Excitatory amino acid receptors, neural membrane phospholipid metabolism and neurological disorders. Brain Res. Rev. 16, 171 191.
52. Farooqui A. A. Horrocks L. A. (1994) Excitotoxicity and neurological disorders: involvement of membrane phospholipids. Int. Rev. Neurobiol. 36, 267 323.
53. Farooqui A. A. Horrocks L. A. (2001) Plasmalogens, phospholipase A2, and docosahexaenoic acid turnover in brain tissue. J. Mol. Neurosci. 16, 263 272.
54. Farooqui A. A. Horrocks L. A. (2005) Signaling and interplay mediated by phospholipases A2, C, and D in LA-N-1 cell nuclei. Reprod. Nutr. Develop. 45, 613 631.
55. Farooqui A. A. Horrocks L. A. (2006a) Glutamate and cytokine-mediated alterations of phospholipids in head injury and spinal cord trauma, in Brain and Spinal Cord Trauma (Banik N., ed Handbook of Neurochemistry (Lajtha, A., ed Springer, New York. In press.
56. Farooqui A. A. Horrocks L. A. (2006b) Phospholipase A2-generated lipid mediators in the brain: The good, the bad, and the ugly. Neuroscientist 12, 245 260.
57. Farooqui A. A., Rammohan K. W. Horrocks L. A. (1989) Isolation, characterization and regulation of diacylglycerol lipases from bovine brain. Ann. NY Acad. Sci. 559, 25 36.
58. Farooqui A. A., Yang H. C., Rosenberger T. A. Horrocks L. A. (1997) Phospholipase A2 and its role in brain tissue. J. Neurochem. 69, 889 901.
59. Farooqui A. A., Litsky M. L., Farooqui T. Horrocks L. A. (1999) Inhibitors of intracellular phospholipase A2 activity: Their neurochemical effects and therapeutical importance for neurological disorders. Brain Res. Bull. 49, 139 153.
60. Farooqui A. A., Horrocks L. A. Farooqui T. (2000a) Deacylation and reacylation of neural membrane glycerophospholipids. J. Mol. Neurosci. 14, 123 135.
61. Farooqui A. A., Horrocks L. A. Farooqui T. (2000b) Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders. Chem. Phys. Lipids 106, 1 29.
62. Farooqui A. A., Ong W. Y., Horrocks L. A. Farooqui T. (2000c) Brain cytosolic phospholipase A2: Localization, role, and involvement in neurological diseases. Neuroscientist 6, 169 180.
63. Farooqui A. A., Ong W. Y., Lu X. R. Horrocks L. A. (2002) Cytosolic phospholipase A2 inhibitors as therapeutic agents for neural cell injury. Curr. Med. Chem. - Anti-Inflammatory & Anti-Allergy Agents 1, 193 204.
64. Farooqui A. A., Antony P., Ong W. Y., Horrocks L. A. Freysz L. (2004a) Retinoic acid-mediated phospholipase A2 signaling in the nucleus. Brain Res. Rev. 45, 179 195.
65. Farooqui A. A., Ong W. Y. Horrocks L. A. (2004b) Biochemical aspects of neurodegeneration in human brain: involvement of neural membrane phospholipids and phospholipases A2. Neurochem. Res. 29, 1961 1977.
66. Farooqui A. A., Horrocks L. A. Farooqui T. (2006a) Choline and ethanolamine glycerophospholipids, in Phospholipids (Tettamanti G. Goracci G., eds.), Handbook of Neurochemistry (Lajtha, A., ed.). Springer, New York. In press.
67. Farooqui A. A., Ong W. Y. Horrocks L. A. (2006b) Inhibitors of brain phospholipase A2 activity: Their neuropharmacologic effects and therapeutic importance for the treatment of neurologic disorders. Pharmacol. Rev. 58, 591 620.
68. Fauconneau B., Stadelmann-Ingrand S., Favrelière S., Baudouin J., Renaud L., Piriou A. Tallineau C. (2001) Evidence against a major role of plasmalogens in the resistance of astrocytes in lactic acid-induced oxidative stress in vitro. Arch. Toxicol. 74, 695 701.
69. Fernstrom J. D. (1999) Effects of dietary polyunsaturated fatty acids on neuronal function. Lipids 34, 161 169.
70. Fiebich B. L., Hüll M., Lieb K., Gyufko K., Berger M. Bauer J. (1997) Prostaglandin E2 induces interleukin-6 synthesis in human astrocytoma cells. J. Neurochem. 68, 704 709.
71. Fitch M. T., Doller C., Combs C. K., Landreth G. E. Silver J. (1999) Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma. J. Neurosci. 19, 8182 8198.
72. Frey R. S., Gao X., Javaid K., Siddiqui S. S., Rahman A. Malik A. B. (2006) Phosphatidylinositol 3-kinase γ signaling through protein kinase Cζ induces NADPH oxidase-mediated oxidant generation and NF-κB activation in endothelial cells. J. Biol. Chem. 281, 16 128 16 138.
73. Fujimoto K., Yao K., Miyazaki T., Hirano H., Nishikawa M., Kimura S., Murayama K. Nonaka M. (1989) The effect of dietary docosahexaenoate on the learning ability of rats, in Health Effects of Fish and Fish Oils (Chandra R. K., ed pp. 275 284. ARTS Biomedical, The Netherlands.
74. Fujita S., Ikegaya Y., Nishikawa M., Nishiyama N. Matsuki N. (2001) Docosahexaenoic acid improves long-term potentiation attenuated by phospholipase A2 inhibitor in rat hippocampal slices. Brit. J. Pharmacol. 132, 1417 1422.
75. de Gaetano G., Donati M. B. Cerletti C. (2003) Prevention of thrombosis and vascular inflammation: benefits and limitations of selective or combined COX-1, COX-2 and 5-LOX inhibitors. Trends Pharmacol. Sci. 24, 245 252.
76. Gasparini L., Ongini E. Wenk G. (2004) Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action. J. Neurochem. 91, 521 536.
77. Gilroy D. W., Newson J., Sawmynaden P. A., Willoughby D. A. Croxtall J. D. (2004) A novel role for phospholipase A2 isoforms in the checkpoint control of acute inflammation. FASEB J. 18, 489 498.
78. Giri S., Khan M., Rattan R., Singh I. Singh A. K. (2006) Krabbe disease: psychosine-mediated activation of phospholipase A2 in oligodendrocyte cell death. J. Lipid Res. 47, 1478 1492.
79. Greco A. Minghetti L. (2004) Isoprostanes as biomarkers and mediators of oxidative injury in infant and adult central nervous system diseases. Curr. Neurovasc. Res. 1, 341 354.
80. Gronert K. (2005) Lipoxins in the eye and their role in wound healing. Prostaglandins Leukot. Essent. Fatty Acids 73, 221 229.
81. Gronert K., Maheshwari N., Khan N., Hassan I. R., Dunn M. Schwartzman M. L. (2005) A role for the mouse 12/15-lipoxygenase pathway in promoting epithelial wound healing and host defense. J. Biol. Chem. 280, 15 267 15 278.
82. Guan Z. Z., Wang Y. A., Cairns N. J., Lantos P. L., Dallner G. Sindelar P. J. (1999) Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease. J. Neuropathol. Exp. Neurol. 58, 740 747.
83. Han X. L., Holtzman D. M. McKeel D. W. Jr. (2001) Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry. J. Neurochem. 77, 1168 1180.
84. Haq E., Contreras M. A., Giri S., Singh I. Singh A. K. (2006) Dysfunction of peroxisomes in twitcher mice brain: A possible mechanism of psychosine-induced disease. Biochem. Biophys. Res. Commun. 343, 229 238.
85. Hashimoto M., Hossain M. S., Yamasaki H., Yazawa K. Masumura S. (1999) Effects of eicosapentaenoic acid and docosahexaenoic acid on plasma membrane fluidity of aortic endothelial cells. Lipids 34, 1297 1304.
86. Hashimoto M., Hossain S., Shimada T., Sugioka K., Yamasaki H., Fujii Y., Ishibashi Y., Oka J. I. Shido O. (2002) Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats. J. Neurochem. 81, 1084 1091.
87. Hashimoto M., Hossain S., Agdul H. Shido O. (2005) Docosahexaenoic acid-induced amelioration on impairment of memory learning in amyloid β-infused rats relates to the decreases of amyloid β and cholesterol levels in detergent-insoluble membrane fractions. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1738, 91 98.
88. Hayakawa M., Ishida N., Takeuchi K., Shibamoto S., Hori T., Oku N., Ito F. Tsujimoto M. (1993) Arachidonic acid-selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factor. J. Biochem. 268, 11 290 11 295.
89. Hays S. J. (1998) Therapeutic approaches to the treatment of neuroinflammatory diseases. Curr. Pharm. Des 4, 335 348.
90. Högyes E., Nyakas C., Kiliaan A., Farkas T., Penke B. Luiten P. G. M. (2003) Neuroprotective effect of developmental docosahexaenoic acid supplement against excitotoxic brain damage in infant rats. Neuroscience 119, 999 1012.
91. Honda Z., Ishii S. Shimizu T. (2002) Platelet-activating factor receptor. J. Biochem. 131, 773 779.
92. Hong S., Gronert K., Devchand P. R., Moussignac R. L. Serhan C. N. (2003) Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells - Autacoids in anti-inflammation. J. Biol. Chem. 278, 14 677 14 687.
93. Horrocks L. A. Farooqui A. A. (2004) Docosahexaenoic acid in the diet: its importance in maintenance and restoration of neural membrane function. Prostaglandins Leukot. Essent. Fatty Acids 70, 361 372.
94. Horrocks L. A. Yeo Y. K. (1999) Health benefits of docosahexaenoic acid (DHA). Pharmacol. Res. 40, 211 225.
95. Hosokawa M., Klegeris A., Maguire J. McGeer P. L. (2003) Expression of complement messenger RNAs and proteins by human oligodendroglial cells. Glia 42, 417 423.
96. Hossain M. S., Hashimoto M. Masumura S. (1998) Influence of docosahexaenoic acid on cerebral lipid peroxide level in aged rats with and without hypercholesterolemia. Neurosci. Lett. 244, 157 160.
97. Hossain M. S., Hashimoto M., Gamoh S. Masumura S. (1999) Antioxidative effects of docosahexaenoic acid in the cerebrum versus cerebellum and brainstem of aged hypercholesterolemic rats. J. Neurochem. 72, 1133 1138.
98. Imbimbo B. P. (2004) The potential role of non-steroidal anti-inflammatory drugs in treating Alzheimer's disease. Expert Opin. Invest. Drugs 13, 1469 1481.
99. Ishii S., Nagase T. Shimizu T. (2002) Platelet-activating factor receptor. Prostaglandins Other Lipid Mediat. 68-69, 599 609.
100. Itoh K. Yamamoto M. (2005) Regulatory role of the COX-2 pathway in the Nrf2-mediated anti-inflammatory response. J. Clin. Biochem. Nutr. 37, 9 18.
101. Itokazu N., Ikegaya Y., Nishikawa M. Matsuki N. (2000) Bidirectional actions of docosahexaenoic acid on hippocampal neurotransmissions in vivo. Brain Res. 862, 211 216.
102. James M. J., Gibson R. A. Cleland L. G. (2000) Dietary polyunsaturated fatty acids and inflammatory mediator production. Am. J. Clin. Nutr. 71, 343S 348S.
103. Jansen G. A. Wanders R. J. A. (1997) Plasmalogens and oxidative stress: Evidence against a major role of plasmalogens in protection against the superoxide anion radical. J. Inherited Metab. Dis. 20, 85 94.
104. Kalmijn S., Feskens E. J. M., Launer L. J. Kromhout D. (1997) Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men. Am. J. Epidemiol. 145, 33 41.
105. Kalmijn S., Van Boxtel M. P. J., Ocké M., Verschuren W. M. M., Kromhout D. Launer L. J. (2004) Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology 62, 275 280.
106. Kantarci A. Van Dyke T. E. (2003) Lipoxins in chronic inflammation. Crit. Rev. Oral Biol. Med. 14, 4 12.
107. Kantarci A. Van Dyke T. E. (2005) Lipoxin signaling in neutrophils and their role in periodontal disease. Prostaglandins Leukot. Essent. Fatty Acids 73, 289 299.
108. Kariko K., Weissman D. Welsh F. A. (2004) Inhibition of toll-like receptor and cytokine signaling - A unifying theme in ischemic tolerance. J. Cereb. Blood Flow Metab. 24, 1288 1304.
109. Kempermann G. Neumann H. (2003) Neuroscience. Microglia: the enemy within? Science 302, 1689 1690.
110. Kettenmann H. Ransom B. R. (2005) Neuroglia. Oxford University Press, New York.
111. Khan M., Haq E., Giri S., Singh I. Singh A. K. (2005) Peroxisomal participation in psychosine-mediated toxicity: Implications for Krabbe's disease. J. Neurosci. Res. 80, 845 854.
112. Kim D. K., Rordorf G., Nemenoff R. A., Koroshetz W. J. Bonventre J. V. (1995) Glutamate stably enhances the activity of two cytosolic forms of phospholipase A2 in brain cortical cultures. Biochem. J. 310, 83 90.
113. Kim H. Y., Akbar M., Lau A. Edsall L. (2000) Inhibition of neuronal apoptosis by docosahexaenoic acid (22:6n-3). Role of phosphatidylserine in antiapoptotic effect. J. Biol. Chem. 275, 35 215 35 223.
114. Kim G. M., Xu J., Xu J. M., Song S. K., Yan P., Ku G., Xu X. M. Hsu C. Y. (2001) Tumor necrosis factor receptor deletion reduces nuclear factor-kappa B activation, cellular inhibitor of apoptosis protein 2 expression, and functional recovery after traumatic spinal cord injury. J. Neurosci. 21, 6617 6625.
115. Kim J. Y., Lee K. H., Lee B. K. Ro J. Y. (2005) Peroxynitrite modulates release of inflammatory mediators from guinea pig lung mast cells activated by antigen-antibody reaction. Int. Arch. Allergy Immunol. 137, 104 114.
116. King V. R., Huang W. L., Dyall S. C., Curran O. E., Priestley J. V. Michael-Titus A. T. (2006) Omega-3 fatty acids improve recovery, whereas omega-6 fatty acids worsen outcome, after spinal cord injury in the adult rat. J. Neurosci. 26, 4672 4680.
117. Kitajka K., Puskás L. G., Zvara A., Hackler L. J., Barceló-Coblijn G., Yeo Y. K. Farkas T. (2002) The role of n-3 polyunsaturated fatty acids in brain: Modulation of rat brain gene expression by dietary n-3 fatty acids. Proc. Natl Acad. Sci. USA 99, 2619 2624.
118. Kolko M., Rodriguez de Turco E. B., Diemer N. H. Bazan N. G. (2002) Secretory phospholipase A2-mediated neuronal cell death involves glutamate ionotropic receptors. NeuroReport 13, 1963 1966.
119. Kreutzberg G. W. (1996) Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19, 312 318.
120. Kronke M. Adam-Klages S. (2002) Role of caspases in TNF-mediated regulation of cPLA2. FEBS Lett. 531, 18 22.
121. Kruger M. C. Schollum L. M. (2005) Is docosahexaenoic acid more effective than eicosapentaenoic acid for increasing calcium bioavailability? Prostaglandins Leukot. Essent. Fatty Acids 73, 327 334.
122. Kuczynski B. Reo N. V. (2006) Evidence that plasmalogen is protective against oxidative stress in the rat brain. Neurochem. Res. 31, 639 656.
123. Kuhn H. O'Donnell V. B. (2006) Inflammation and immune regulation by 12/15-lipoxygenases. Prog. Lipid Res. 45, 334 356.
124. Kuijpers T. W., Van den Berg J. M., Tool A. T. J. Roos D. (2001) The impact of platelet-activating factor (PAF)-like mediators on the functional activity of neutrophils: anti-inflammatory effects of human PAF-acetylhydrolase. Clin. Exp. Immunol. 123, 412 420.
125. Lahaie I., Hardy P., Hou X. et al. (1998) A novel mechanism for vasoconstrictor action of 8-isoprostaglandin F2α on retinal vessels. Am. J. Physiol 274, R1406 R1416.
126. Langelier B., Alessandri J. M., Perruchot M. H., Guesnet P. Lavialle M. (2005) Changes of the transcriptional and fatty acid profiles in response to n-3 fatty acids in SH-SY5Y neuroblastoma cells. Lipids 40, 719 728.
127. Lazarewicz J. W., Wroblewski J. T. Costa E. (1990) N-methyl-d-aspartate- sensitive glutamate receptors induce calcium-mediated arachidonic acid release in primary cultures of cerebellar granule cells. J. Neurochem. 55, 1875 1881.
128. Lee T. C. (1998) Biosynthesis and possible biological functions of plasmalogens. Biochim. Biophys. Acta Lipids Lipid Metab. 1394, 129 145.
129. Lee J. Y., Plakidas A., Lee W. H., Heikkinen A., Chanmugam P., Bray G. Hwang D. H. (2003) Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. J. Lipid Res. 44, 479 486.
130. Lee H., Villacreses N. E., Rapoport S. I. Rosenberger T. A. (2004) In vivo imaging detects a transient increase in brain arachidonic acid metabolism: a potential marker of neuroinflammation. J. Neurochem. 91, 936 945.
131. Li Q., Ma J., Tan L., Wang C., Li N., Li Y., Xu G. Li J. (2006a) Effect of docosahexaenoic acid on interleukin-2 receptor signaling pathway in lipid rafts. Sci. China Ser. C-Life Sci. 49, 63 72.
132. Li Q., Tan L., Wang C., Li N., Li Y., Xu G. Li J. (2006b) Polyunsaturated eicosapentaenoic acid changes lipid composition in lipid rafts. Eur. J. Nutr. 45, 144 151.
133. Lim W. S., Gammack J. K., Van Niekerk J. Dangour A. D. (2006) Omega 3 fatty acid for the prevention of dementia. Cochrane Database of Systematic Reviews NIL.
134. Lin T. N., Wang Q., Simonyi A., Chen J. J., Cheung W. M., He Y. Y., Xu J., Sun A. Y., Hsu C. Y. Sun G. Y. (2004) Induction of secretory phospholipase A2 in reactive astrocytes in response to transient focal cerebral ischemia in the rat brain. J. Neurochem. 90, 637 645.
135. Lloret S. Moreno J. J. (1995) Ca2+ influx, phosphoinositide hydrolysis, and histamine release induced by lysophosphatidylserine in mast cells. J. Cell Physiol 165, 89 95.
136. Lonergan P. E., Martin D. S. D., Horrobin D. F. Lynch M. A. (2004) Neuroprotective actions of eicosapentaenoic acid on lipopolysaccharide-induced dysfunction in rat hippocampus. J. Neurochem. 91, 20 29.
137. Lovas G., Palkovits M. Komoly S. (2000) Increased c-Jun expression in neurons affected by lysolecithin-induced demyelination in rats. Neurosci. Lett. 292, 71 74.
138. Luberto C. Hannun Y. A. (1998) Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation. Does sphingomyelin synthase account for the putative phosphatidylcholine-specific phospholipase C?. J. Biol. Chem. 273, 14 550 14 559.
139. Lucas S. M., Rothwell N. J. Gibson R. M. (2006) The role of inflammation in CNS injury and disease. Br. J. Pharmacol. 147 (Suppl. 1 S232 S240.
140. Lukiw W. J., Cui J. G., Marcheselli V. L., Bodker M., Botkjaer A., Gotlinger K., Serhan C. N. Bazan N. G. (2005) A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J. Clin. Invest. 115, 2774 2783.
141. Machado F. S., Johndrow J. E., Esper L., Dias A., Bafica A., Serhan C. N. Aliberti J. (2006) Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent. Nature Med. 12, 330 334.
142. Machleidt T., Kramer B., Adam D., Neumann B., Schutze S., Wiegmann K. Kronke M. (1996) Function of the p55 tumor necrosis factor receptor "death domain" mediated by phosphatidylcholine-specific phospholipase C. J. Exp. Med. 184, 725 733.
143. Maclennan K. M., Smith P. F. Darlington C. L. (1996) Platelet-activating factor in the CNS. Prog. Neurobiol. 50, 585 596.
144. Maeba R. Ueta N. (2004) A novel antioxidant action of ethanolamine plasmalogens in lowering the oxidizability of membranes. Biochem. Soc. Trans. 32, 141 143.
145. Marcheselli V. L., Hong S., Lukiw W. J. et al. (2003) Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J. Biol. Chem. 278, 43 807 43 817.
146. Maresz K., Carrier E. J., Ponomarev E. D., Hillard C. J. Dittel B. N. (2005) Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli. J. Neurochem. 95, 437 445.
147. Marszalek J. R. Lodish H. F. (2005) Docosahexaenoic acid, fatty acid-interacting proteins, and neuronal function: breastmilk and fish are good for you. Annu. Rev. Cell Dev. Biol. 21, 633 657.
148. Martínez M., Vázquez E., García-Silva M. T., Manzanares J., Bertran J. M., Castelló F. Mougan I. (2000) Therapeutic effects of docosahexaenoic acid ethyl ester in patients with generalized peroxisomal disorders. Am. J. Clin. Nutr. 71, 376S 385S.
149. Mazière C., Conte M. A., Degonville J., Ali D. Mazière J. C. (1999) Cellular enrichment with polyunsaturated fatty acids induces an oxidative stress and activates the transcription factors AP1 and NFκB. Biochem. Biophys. Res. Commun. 265, 116 122.
150. McGahon B. M., Martin D. S. D., Horrobin D. F. Lynch M. A. (1999) Age-related changes in synaptic function: Analysis of the effect of dietary supplementation with omega-3 fatty acids. Neuroscience 94, 305 314.
151. Mhatre M., Floyd R. A. Hensley K. (2004) Oxidative stress and neuroinflammation in Alzheimer's disease and amyotrophic lateral sclerosis: Common links and potential therapeutic targets. J. Alzheimer's Dis. 6, 147 157.
152. Miller A. A., Drummond G. R. Sobey C. G. (2006) Novel isoforms of NADPH-oxidase in cerebral vascular control. Pharmacol. Ther. 111, 928 948.
153. Mills S. C., Windsor A. C. Knight S. C. (2005) The potential interactions between polyunsaturated fatty acids and colonic inflammatory processes. Clin. Exp. Immunol. 142, 216 228.
154. Minami M., Katayama T. Satoh M. (2006) Brain cytokines and chemokines: Roles in ischemic injury and pain. J. Pharmacol. Sci. 100, 461 470.
155. Minghetti L., Ajmone-Cat M. A., De Berardinis M. A. De Simone R. (2005) Microglial activation in chronic neurodegenerative diseases: roles of apoptotic neurons and chronic stimulation. Brain Res. Rev. 48, 251 256.
156. Mohri I., Taniike M., Taniguchi H. et al. (2006) Prostaglandin D2-mediated microglia/astrocyte interaction enhances astrogliosis and demyelination in twitcher. J. Neurosci. 26, 4383 4393.
157. Moraes L. A., Piqueras L. Bishop-Bailey D. (2006) Peroxisome proliferator-activated receptors and inflammation. Pharmacol. Ther. 110, 371 385.
158. Moran J. M., Buller R. M. L., McHowat J., Turk J., Wohltmann M., Gross R. W. Corbett J. A. (2005) Genetic and pharmacologic evidence that calcium-independent phospholipase A2β regulates virus-induced inducible nitric-oxide synthase expression by macrophages. J. Biol. Chem. 280, 28 162 28 168.
159. Mori T. A. Beilin L. J. (2004) Omega-3 fatty acids and inflammation. Curr. Atheroscler. Rep. 6, 461 467.
160. Morioka N., Takeda K., Kumagai K., Hanada T., Ikoma K., Hide I., Inoue A. Nakata Y. (2002) Interleukin-1β-induced substance P release from rat cultured primary afferent neurons driven by two phospholipase A2 enzymes: secretory type IIA and cytosolic type IV. J. Neurochem. 80, 989 997.
161. Morrow J. D. (2006) The isoprostanes - Unique products of arachidonate peroxidation: Their role as mediators of oxidant stress. Curr. Pharmaceut. Design 12, 895 902.
162. Morrow J. D., Awad J. A., Boss H. J., Blair I. A., Roberts L. J. II. (1992) Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc. Natl Acad. Sci. USA 89, 10 721 10 725.
163. Morrow J. D., Tapper A. R., Zackert W. E., Yang J., Sanchez S. C., Montine T. J., Roberts L. J. II. (1999) Formation of novel isoprostane-like compounds from docosahexaenoic acid. Adv. Exp. Med. Biol. 469, 343 347.
164. Moses G. S. D., Jensen M. D., Lue L. F., Walker D. G., Sun A. Y., Simonyi A. Sun G. Y. (2006) Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease. J. Neuroinflammation. 3, 28 38.
165. Mukherjee P. K., Marcheselli V. L., Serhan C. N. Bazan N. G. (2004) Neuroprotectin D1: A docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc. Natl Acad. Sci. USA 101, 8491 8496.
166. Murakami M. Kudo I. (2006) Prostaglandin E synthase: A novel drug target for inflammation and cancer. Curr. Pharmaceut. Design 12, 943 954.
167. Murakami M., Shimbara S., Kambe T., Kuwata H., Winstead M. V., Tischfield J. A. Kudo I. (1998) The functions of five distinct mammalian phospholipase A2 s in regulating arachidonic acid release - Type IIA and type V secretory phospholipase A2 s are functionally redundant and act in concert with cytosolic phospholipase A2. J. Biol. Chem. 273, 14 411 14 423.
168. Murakami M., Kambe T., Shimbara S. Kudo I. (1999) Functional coupling between various phospholipase A2 s and cyclooxygenases in immediate and delayed prostanoid biosynthetic pathways. J. Biol. Chem. 274, 3103 3115.
169. Murphy R. C. (2001) Free-radical-induced oxidation of arachidonoyl plasmalogen phospholipids: Antioxidant mechanism and precursor pathway for bioactive eicosanoids. Chem. Res. Toxicol. 14, 463 472.
170. Neto H. C. C. F., Stafforini D. M., Prescott S. M. Zimmerman G. A. (2005) Regulating inflammation through the anti-inflammatory enzyme platelet-activating factor-acetylhydrolase. Mem. Inst. Oswaldo Cruz 100, 83 91.
171. Noda M., Kettenmann H. Wada K. (2006) Anti-inflammatory effects of kinins via microglia in the central nervous system. Biol. Chem. 387, 167 171.
172. Nordvik I., Myhr K. M., Nyland H. Bjerve K. S. (2000) Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients. Acta Neurol. Scand. 102, 143 149.
173. Norel X. Brink C. (2004) The quest for new cysteinyl-leukotriene and lipoxin receptors: recent clues. Pharmacol. Ther. 103, 81 94.
174. Nourooz-Zadeh J., Halliwell B. Änggård E. E. (1997) Evidence for the formation of F3-isoprostanes during peroxidation of eicosapentaenoic acid. Biochem. Biophys. Res. Commun. 236, 467 472.
175. Nourooz-Zadeh J., Liu E. H. C., Yhlen B., Änggård E. E. Halliwell B. (1999) F4-isoprostanes as specific marker of docosahexaenoic acid peroxidation in Alzheimer's disease. J. Neurochem. 72, 734 740.
176. Olivo S. E. Hilakivi-Clarke L. (2005) Opposing effects of prepubertal low- and high-fat n-3 polyunsaturated fatty acid diets on rat mammary tumorigenesis. Carcinogenesis 26, 1563 1572.
177. Ong L. W., Jiang B., Tang N., Yeo J. F., Wei S., Farooqui A. A. Ong W. Y. (2006) Differential effects of polyunsaturated fatty acids on exocytosis in rat pheochromocytoma-12 cells. Neurochem. Res. 31, 41 48.
178. Ousman S. S. David S. (2000) Lysophosphatidylcholine induces rapid recruitment and activation of macrophages in the adult mouse spinal cord. Glia 30, 92 104.
179. Park E. J., Park S. Y., Joe E. H. Jou I. (2003) 15d-PGJ2 and rosilglitazone suppress Janus kinase-STAT inflammatory signaling through induction of suppressor of cytokine signaling 1 (SOCS1) and SOCS3 in glia. J. Biol. Chem. 278, 14 747 14 752.
180. Pater C., Compagnone D., Luszick J. Verboom C. N. (2003) Effect of Omacor on HRV parameters in patients with recent uncomplicated myocardial infarction - A randomized, parallel group, double-blind, placebo-controlled trial: study design [ISRCTN75358739]. Curr. Control Trials Cardiovasc. Med. 4, 2.
181. Perry V. H. Gordon S. (1991) Macrophages and the nervous system. Int. Rev. Cytol. 125, 203 244.
182. Pettegrew J. W., Panchalingam K., Hamilton R. L. McClure R. J. (2001) Brain membrane phospholipid alterations in Alzheimer's disease. Neurochem. Res. 26, 771 782.
183. Phillis J. W., Horrocks L. A. Farooqui A. A. (2006) Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders. Brain Res. Rev. 52, 201 243.
184. Piomelli D. (2003) The molecular logic of endocannabinoid signalling. Nature Rev. Neurosci. 4, 873 884.
185. Poumès-Ballihaut C., Langelier B., Houlier F., Alessandri J. M., Durand G., Latge C. Guesnet P. (2001) Comparative bioavailability of dietary alpha-linolenic and docosahexaenoic acids in the growing rat. Lipids 36, 793 800.
186. Puri B. K. (2005) Treatment of Huntington's disease with eicosapentaenoic acid, in Nutrients, Stress and Medical Disorders (Yehuda S. Mostofsky D. I., eds pp. 279 286. Health (Series). Humana Press Inc., Totowa.
187. Puskás L. G., Kitajka K., Nyakas C., Barcelo-Coblijn G. Farkas T. (2003) Short-term administration of omega 3 fatty acids from fish oil results in increased transthyretin transcription in old rat hippocampus. Proc. Natl Acad. Sci. USA 100, 1580 1585.
188. Rapoport S. I. (1999) In vivo fatty acid incorporation into brain phospholipids in relation to signal transduction and membrane remodeling. Neurochem. Res. 24, 1403 1415.
189. Ray S. K., Hogan E. L. Banik N. L. (2003) Calpain in the pathophysiology of spinal cord injury: neuroprotection with calpain inhibitors. Brain Res. Rev. 42, 169 185.
190. Roberts L. J., II. Fessel J. P. (2004) The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation. Chem. Phys. Lipids 128, 173 186.
191. Roberts L. J., II., Montine T. J., Markesbery W. R., Tapper A. R., Hardy P., Chemtob S., Dettbarn W. D. Morrow J. D. (1998) Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J. Biol. Chem. 273, 13 605 13 612.
192. Roberts L. J., II., Fessel J. P. Davies S. S. (2005) The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation. Brain Path. 15, 143 148.
193. Rockwell C. E., Snider N. T., Thompson J. T., Heuvel J. P. V. Kaminski N. E. (2006) Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor γ independently of cannabinoid receptors 1 and 2. Molec. Pharmacol. 70, 101 111.
194. Rodriguez de Turco E. B., Jackson F. R., DeCoster M. A., Kolko M. Bazan N. G. (2002) Glutamate signalling and secretory phospholipase A2 modulate the release of arachidonic acid from neuronal membranes. J. Neurosci. Res. 68, 558 567.
195. Rordorf G., Uemura Y. Bonventre J. V. (1991) Characterization of phospholipase A2 (PLA2) activity in gerbil brain: Enhanced activities of cytosolic, mitochondrial, and microsomal forms after ischemia and reperfusion. J. Neurosci. 11, 1829 1836.
196. Rosenberger T. A., Villacreses N. E., Hovda J. T., Bosetti F., Weerasinghe G., Wine R. N., Harry G. J. Rapoport S. I. (2004) Rat brain arachidonic acid metabolism is increased by a 6-day intracerebral ventricular infusion of bacterial lipopolysaccharide. J. Neurochem. 88, 1168 1178.
197. Rothwell N. J. (1999) Annual review prize lecture cytokines - killers in the brain? J. Physiol. (London) 514, 3 17.
198. Rubenfeld J., Guo J., Sookrung N., Chen R., Chaicumpa W., Casolaro V., Zhao Y., Natarajan V. Georas S. (2006) Lysophosphatidic acid enhances interleukin-13 gene expression and promoter activity in T cells. Am. J. Physiol Lung Cell Mol. Physiol 290, L66 L74.
199. Rubin B. B., Downey G. P., Koh A. et al. (2005) Cytosolic phospholipase A2-α is necessary for platelet-activating factor biosynthesis, efficient neutrophil-mediated bacterial killing, and the innate immune response to pulmonary infection - cPLA2-α does not regulate neutrophil NADPH oxidase activity. J. Biol. Chem. 280, 7519 7529.
200. Saario S. M., Savinainen J. R., Laitinen J. T., Jarvinen T. Niemi R. (2004) Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes. Biochem. Pharmacol. 67, 1381 1387.
201. Samadi P., Gregoire L., Rouillard C., Bedard P. J., Di Paolo T. Levesque D. (2006) Docosahexaenoic acid reduces levodopa-induced dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys. Ann. Neurol. 59, 282 288.
202. Schilling T., Lehmann F., Ruckert B. Eder C. (2004) Physiological mechanisms of lysophosphatidylcholine-induced de-ramification of murine microglia. J. Physiol. (London) 557, 105 120.
203. Schmid H. H. O., Schmid P. C. Berdyshev E. V. (2002) Cell signaling by endocannabinoids and their congeners: questions of selectivity and other challenges. Chem. Phys. Lipids 121, 111 134.
204. Schütze S., Potthoff K., Machleidt T., Berkovic D., Wiegmann K. Krönke M. (1992) TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 71, 765 776.
205. Serhan C. N. (1994) Lipoxin biosynthesis and its impact in inflammatory and vascular events. Biochim. Biophys. Acta 1212, 1 25.
206. Serhan C. N. (2004) A search for endogenous mechanisms of anti-inflammation uncovers novel chemical mediators: missing links to resolution. Histochem. Cell Biol. 122, 305 321.
207. Serhan C. N. (2005a) Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution. Prostaglandins Leukot. Essent. Fatty Acids 73, 141 162.
208. Serhan C. N. (2005b) Novel ω-3-derived local mediators in anti-inflammation and resolution. Pharmacol. Ther. 105, 7 21.
209. Serhan C. N. (2006) Novel chemical mediators in the resolution of inflammation: Resolvins and protectins. Anesthesiol. Clinics North Am. 24, 341 364.
210. Serhan C. N. Levy B. (2003) Novel pathways and endogenous mediators in anti-inflammation and resolution. Chem. Immunol. Allergy 83, 115 145.
211. Serhan C. N. Savill J. (2005) Resolution of inflammation: The beginning programs the end. Nature Immunol. 6, 1191 1197.
212. Serhan C. N., Arita M., Hong S. Gotlinger K. (2004) Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers. Lipids 39, 1125 1132.
213. Sharkey J., Kelly J. S. Butcher S. P. (1997) Inflammatory responses to cerebral ischemia, in Clinical Pharmacology of Cerebral Ischemia (Horst G. J. Korf J., eds pp. 235 265. Humana Press, Totowa, NJ.
214. Shiraki T., Kamiya N., Shiki S., Kodama T. S., Kakizuka A. Jingami H. (2005) α,β-Unsaturated ketone is a core moiety of natural ligands for covalent binding to peroxisome proliferator-activated receptor γ. J. Biol. Chem. 280, 14 145 14 153.
215. Shmelzer Z., Haddad N., Admon E., Pessach I., Leto T. L., Eitan-Hazan Z., Hershfinkel M. Levy R. (2003) Unique targeting of cytosolic phospholipase A2 to plasma membranes mediated by the NADPH oxidase in phagocytes. J. Cell Biol. 162, 683 692.
216. Shohami E., Shapira Y., Yadid G., Reisfeld N. Yedgar S. (1989) Brain phospholipase A2 is activated after experimental closed head injury in the rat. J. Neurochem. 53, 1541 1546.
217. Sindelar P. J., Guan Z. Z., Dallner G. Ernster L. (1999) The protective role of plasmalogens in iron-induced lipid peroxidation. Free Radic. Biol. Med. 26, 318 324.
218. Snyder F. (1995) Platelet-activating factor: the biosynthetic and catabolic enzymes. Biochem. J. 305, 689 705.
219. Söderberg M., Edlund C., Kristensson K. Dallner G. (1990) Lipid compositions of different regions of the human brain during aging. J. Neurochem. 54, 415 423.
220. Song C. (2003) Effects of n-3 fatty acids on depressive symptoms induced by proinflammatory cytokines in animals, in Phospholipid Spectrum Disorders in Psychiatry and Neurology (Peet M., Glen L. Horrobin D. F., eds pp. 415 422. Marius Press, Carnforth, Lancashire.
221. Stokes C. E. Hawthorne J. N. (1987) Reduced phosphoinositide concentration in anterior temporal cortex of Alzheimer's diseased brains. J. Neurochem. 48, 1018 1021.
222. Strokin M., Sergeeva M. Reiser G. (2004) Role of Ca2 + -independent phospholipase A2 and n-3 polyunsaturated fatty acid docosahexaenoic acid in prostanoid production in brain: perspectives for protection in neuroinflammation. Int. J. Devl. Neurosci. 22, 551 557.
223. Strokin M., Chechneva O., Reymann K. G. Reiser G. (2006) Neuroprotection of rat hippocampal slices exposed to oxygen-glucose deprivation by enrichment with docosahexaenoic acid and by inhibition of hydrolysis of docosahexaenoic acid-containing phospholipids by calcium independent phospholipase A2. Neuroscience 140, 547 553.
224. Sun D., Newman T. A., Perry V. H. Weller R. O. (2004a) Cytokine-induced enhancement of autoimmune inflammation in the brain and spinal cord: implications for multiple sclerosis. Neuropathol. Appl. Neurobiol. 30, 374 384.
225. Sun G. Y., Xu J., Jensen M. D. Simonyi A. (2004b) Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases. J. Lipid Res. 45, 205 213.
226. Takeuchi H., Mizuno T., Zhang G. Q., Wang J. Y., Kawanokuchi J., Kuno R. Suzumura A. (2005) Neuritic beading induced by activated microglia is an early feature of neuronal dysfunction toward neuronal death by inhibition of mitochondrial respiration and axonal transport. J. Biol. Chem. 280, 10 444 10 454.
227. Taylor W. A. (1988) Effects of Impact Injury of Rat Spinal Cord on Activities of Some Enzymes of Lipid Hydrolysis, Dissertation, The Ohio State University, Columbus, Ohio.
228. Tillman T. S. Cascio M. (2003) Effects of membrane lipids on ion channel structure and function. Cell Biochem. Biophys. 38, 161 190.
229. Tokuoka S. M., Ishii S., Kawamura N., Satoh M., Shimada A., Sasaki S., Hirotsune S., Wynshaw-Boris A. Shimizu T. (2003) Involvement of platelet-activating factor and LIS1 in neuronal migration. Eur. J. Neurosci. 18, 563 570.
230. Tsutsumi T., Yamauchi E., Suzuki E., Watanabe S., Kobayashi T. Okuyama H. (1995) Effect of a high α-linolenate and high linoleate diet on membrane-associated enzyme activities in rat brain-modulation of Na+, K + - ATPase activity at suboptimal concentrations of ATP. Biol. Pharm. Bull. 18, 664 670.
231. Verlengia R., Gorjão R., Kanunfre C. C., Bordin S., Martins de Lima T., Fernandes Martins E., Newsholme P. Curi R. (2004) Effects of EPA and DHA on proliferation, cytokine production, and gene expression in Raji cells. Lipids 39, 857 864.
232. Walsh D. M. Selkoe D. J. (2004) Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 44, 181 193.
233. Walter L. Stella N. (2004) Cannabinoids and neuroinflammation. Brit. J. Pharmacol. 141, 775 785.
234. Walter L., Franklin A., Witting A., Wade C., Xie Y. H., Kunos G., Mackie K. Stella N. (2003) Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J. Neurosci. 23, 1398 1405.
235. Watanabe S., Doshi M. Hamazaki T. (2003) n-3 polyunsaturated fatty acid (PUFA) deficiency elevates and n-3 PUFA enrichment reduces brain 2-arachidonoylglycerol level in mice. Prostaglandins Leukot. Essent. Fatty Acids 69, 51 59.
236. Watkins L. R., Milligan E. D. Maier S. F. (2001) Glial activation: a driving force for pathological pain. Trends Neurosci. 24, 450 455.
237. Wells K., Farooqui A. A., Liss L. Horrocks L. A. (1995) Neural membrane phospholipids in Alzheimer disease. Neurochem. Res. 20, 1329 1333.
238. Weylandt K. H. Kang J. X. (2005) Rethinking lipid mediators. Lancet 366, 618 620.
239. Wilson C. J., Finch C. E. Cohen H. J. (2002) Cytokines and cognition - the case for a head-to-toe inflammatory paradigm. J. Am. Geriatr. Soc. 50, 2041 2056.
240. Woo C. H., Eom Y. W., Yoo M. H., You H. J., Han H. J., Song W. K., Yoo Y. J., Chun J. S. Kim J. H. (2000) Tumor necrosis factor-α generates reactive oxygen species via a cytosolic phospholipase A2-linked cascade. J. Biol. Chem. 275, 32 357 32 362.
241. Wood P. L. (1998) Neuroinflammation: Mechanisms and Management. Humana Press, Totowa, New Jersey.
242. Wu D. Meydani S. N. (1998) n-3 polyunsaturated fatty acids and immune function. Proc. Nutr. Soc. 57, 503 509.
243. Wu S. M., Patel D. D. Pizzo S. V. (1998) Oxidized α2-macroglobulin (α2 M) differentially regulates receptor binding by cytokines/growth factors: implications for tissue injury and repair mechanisms in inflammation. J. Immunol. 161, 4356 4365.
244. Xia S. H., Wang J. D., He C. W., Hong S., Serhan C. N. Kang J. X. (2006) Melanoma growth is reduced in fat-1 transgenic mice: Impact of omega- 6/omega-3 essential fatty acids. Proc. Natl Acad. Sci. USA 103, 12 499 12 504.
245. Xiao Y. F. Li X. Y. (1999) Polyunsaturated fatty acids modify mouse hippocampal neuronal excitability during excitotoxic or convulsant stimulation. Brain Res. 846, 112 121.
246. Xing Z., Gauldie J., Cox G., Baumann H., Jordana M., Lei X. F. Achong M. K. (1998) IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J. Clin. Invest. 101, 311 320.
247. Yagami T., Ueda K., Asakura K., Hata S., Kuroda T., Sakaeda T., Takasu N., Tanaka K., Gemba T. Hori Y. (2002) Human group IIA secretory phospholipase A2 induces neuronal cell death via apoptosis. Mol. Pharmacol. 61, 114 126.
248. Yamamoto Y. Gaynor R. B. (2004) IκB kinases: key regulators of the NF-κB pathway. Trends Biochem. Sci. 29, 72 79.
249. Yamazaki R., Kusunoki N., Matsuzaki T., Hashimoto S. Kawai S. (2002) Nonsteroidal anti-inflammatory drugs induce apoptosis in association with activation of peroxisome proliferator-activated receptor γ in rheumatoid synovial cells. J. Pharmacol. Exp. Ther. 302, 18 25.
250. Yehuda S., Rabinovitz S., Carasso R. L. Mostofsky D. I. (2002) The role of polyunsaturated fatty acids in restoring the aging neuronal membrane. Neurobiol. Aging 23, 843 853.
251. Yehuda S., Rabinovitz S. Mostofsky D. I. (2005) Essential fatty acids and the brain: from infancy to aging. Neurobiol. Aging 26 (Suppl 1 98 102.
252. Yeo J. F., Ong W. Y., Ling S. F. Farooqui A. A. (2004) Intracerebroventricular injection of phospholipases A2 inhibitors modulates allodynia after facial carrageenan injection in mice. Pain 112, 148 155.
253. Yin H. Y., Musiek E. S., Gao L., Porter N. A. Morrow J. D. (2005) Regiochemistry of neuroprostanes generated from the peroxidation of docosahexaenoic acid in vitro and in vivo. J. Biol. Chem. 280, 26 600 26 611.
254. Yu N., Maciejewski-Lenoir D., Bloom F. E. Magistretti P. J. (1995) Tumor necrosis factor-α and interleukin-1α enhance glucose utilization by astrocytes: involvement of phospholipase A2. Molec. Pharmacol. 48, 550 558.
255. Yuen A. W. C., Sander J. W., Fluegel D., Patsalos P. N., Bell G. S., Johnson T. Koepp M. J. (2005) Omega-3 fatty acid supplementation in patients with chronic epilepsy: A randomized trial. Epilepsy & Behavior 7, 253 258.
256. Zhang J. Rivest S. (2001) Anti-inflammatory effects of prostaglandin E2 in the central nervous system in response to brain injury and circulating lipopolysaccharide. J. Neurochem. 76, 855 864.
257. Zhang X., Dong F., Ren J., Driscoll M. J. Culver B. (2005) High dietary fat induces NADPH oxidase-associated oxidative stress and inflammation in rat cerebral cortex. Exp Neurol. 191, 318 325.
258. Zhao Y., Joshi-Barve S., Barve S. Chen L. H. (2004) Eicosapentaenoic acid prevents LPS-induced TNF-α expression by preventing NF-κB activation. J. Am. Coll. Nutr. 23, 71 78.
259. Zimmer L., Delion-Vancassel S., Durand G., Guilloteau D., Bodard S., Besnard J. C. Chalon S. (2000) Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n-3 polyunsaturated fatty acids. J. Lipid Res. 41, 32 40.
260. Zimmerman G. A., Elstad M. R., Lorant D. E., McIntyre T. M., Prescott S. M., Topham M. K., Weyrich A. S. Whatley R. E. (1996) Platelet-activating factor (PAF): signalling and adhesion in cell-cell interactions. Adv. Exp. Med. Biol. 416, 297 304.
261. Zoeller R. A., Lake A. C., Nagan N., Gaposchkin D. P., Legner M. A. Lieberthal W. (1999) Plasmalogens as endogenous antioxidants: somatic cell mutants reveal the importance of the vinyl ether. Biochem. J. 338, 769 776.